Asia Deal Watch: Rona Takes On Sanofi’s siRNA Platform

 
• By Lisa Takagi, Jung Won Shin, Dexter Jie Yan, and Joseph Haas

Rona hopes technology acquired from Sanofi will enhance its RNA capabilities in liver and non-liver indications. NeuroFront gets Greater China and Singapore rights to Novaremed’s neuropathic pain drug.

Asia Deal Watch
• Source: Alamy

More from Deal Watch

More from Deals